Medical cannabis is legal in the UK. This means that in some circumstances ... When looking at medical cannabis, the two most important are cannabidiol (CBD) and tetrahydrocannabinol (THC). CBD does ...

Cannabidiol (CBD) is increasingly recognized for its role as an antiseizure medication, especially for the management of Drug-Resistant Epilepsy (DRE). This ...

Synthetic cannabinoids, a class of new psychoactive substances, bind to cannabinoid receptors CB1 and CB2 much more strongly than tetrahydrocannabinol (THC) and cannabidiol (CBD), raising public ...

CBD-infused Products Market Expected to Grow at a CAGR of 30.6% from 2025 to 2032 REDDING, Calif., March 12, 2025 /PRNewswire/ -- According to a new market research report titled, 'CBD-infused ...

According to a new market research report titled, 'CBD-infused Products Market Size, Share, Forecast, & Trends Analysis by ...

Home Bargains fans have dubbed the oil a 'little bottle of heaven', which they swear helps them to 'sleep soundly.' ...

Kentucky legislative committee advances a ban on the sale of hemp-derived beverages in the state until summer of 2026.

Aldi has announced it will soon be offering a solution to people struggling with sleep as it launches a new product priced at ...

Avecho Biotechnology (ASX: AVE) has signed a ten-year development and licensing agreement with Sandoz (SWX: SDZ) for the ...

Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho ...

Sandoz has agreed to an upfront licensing fee of US$3M (approx. A$4.8M [1]) for the exclusive commercial rights to the CBD product for insomnia in Australia. Avecho will continue to fund and oversee ...